CytomX Therapeutics, Inc 10-Q for FY2025 Q3
CytomX Therapeutics, Inc. (CTMX)
10-Q
2025-11-06
For: 2025-09-30
View Original
Added on
April 09, 2026
About this 10-Q
CytomX Therapeutics, Inc filed this 10-Q on November 6, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $5.96M
- down 82.2% from $33.43M a year earlier
- Net loss
- $14.23M
- compared with net income of $5.74M a year earlier